- Home
- CM vs MDT Comparison
CM vs MDT Comparison
Compare CM & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CM | MDT |
|---|---|---|
| Founded | 1867 | 1949 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2B | 131.9B |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CM | MDT |
|---|---|---|
| Price | $95.34 | $87.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $107.50 | ★ $109.82 |
| AVG Volume (30 Days) | 984.1K | ★ 7.8M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | 2.96% | ★ 3.25% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | $23.37 | $8.91 |
| Revenue Next Year | $3.91 | $6.75 |
| P/E Ratio | ★ $15.80 | $31.72 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $53.62 | $79.55 |
| 52 Week High | $105.00 | $106.33 |
Technical Indicators
Market Signals| Indicator | CM | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 22.17 |
| Support Level | $94.41 | $85.41 |
| Resistance Level | $98.50 | $88.52 |
| Average True Range (ATR) | 2.17 | 1.91 |
| MACD | -0.74 | -0.96 |
| Stochastic Oscillator | 2.03 | 2.20 |
Price Performance
Historical ComparisonAbout CM Canadian Imperial Bank of Commerce
Canadian Imperial Bank of Commerce is Canada's fifth-largest bank with over CAD 1.1 trillion in assets at the end of fiscal 2025. It operates four business segments: Canadian retail and business banking, Canadian commercial banking and wealth management, US commercial banking and wealth management, and capital markets. It serves approximately 14 million personal banking and business customers, primarily in Canada and the US.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.